/POSC
POSC Stock - Positron Corporation
Healthcare|Medical - DevicesOTC
$1.55-2.08%
$0.03 (-2.08%) • Dec 19
65
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.49
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.91
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $1.71
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for POSC
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$1.53 – $1.57
TARGET (TP)$1.78
STOP LOSS$1.43
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.74
52W High$2.94
52W Low$0.92
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $587,500 | $734,666 | $727,583 | $881,951 | $823,745 |
| Gross Profit | $-341,984 | $-353,465 | $-81,776 | $132,847 | $160,781 |
| Gross Margin | -58.2% | -48.1% | -11.2% | 15.1% | 19.5% |
| Operating Income | $-2,214,012 | $-1,360,750 | $-2,682,930 | $-763,570 | $-62,070 |
| Net Income | $-2,388,091 | $-1,638,703 | $-2,859,007 | $-595,075 | $-62,071 |
| Net Margin | -406.5% | -223.1% | -392.9% | -67.5% | -7.5% |
| EPS | $-0.09 | $-0.07 | $-0.12 | $-0.03 | $-0.01 |
Company Overview
Positron Corporation, a nuclear medicine healthcare company, specializes in the business of cardiac positron emission tomography (PET) imaging in the United States. It offers attrius PET scanner, clinical and technical services, and financing solutions enables healthcare providers to accurately diagnose cardiac disease, improve patient outcomes, and practice cost effective medicines. Positron Corporation was incorporated in 1983 and is based in Niagara Falls, New York.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
POSCBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.03
Q4 2025
EPS Surprise History
Q3 14
No data
Q4 14
No data
Q1 15
No data
Q2 15
No data
Q3 15
No data
Q4 15
No data
Q2 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Oct 28, 2025 | — | $-0.03 | — | — |
Q2 2025 | May 15, 2025 | — | $-0.05 | — | — |
Q4 2015 | Nov 23, 2015 | — | $-0.02 | — | — |
Q3 2015 | Aug 14, 2015 | — | $-0.03 | — | — |
Q2 2015 | May 15, 2015 | — | $-0.04 | — | — |
Q1 2015 | Mar 31, 2015 | — | $-0.07 | — | — |
Q4 2014 | Nov 14, 2014 | — | $-0.13 | — | — |
Q3 2014 | Aug 14, 2014 | — | $-0.02 | — | — |
Q2 2014 | May 15, 2014 | — | $-0.24 | — | — |
Q4 2013 | Dec 31, 2013 | — | $-0.49 | — | — |
Q4 2013 | Nov 14, 2013 | — | $-0.38 | — | — |
Q3 2013 | Aug 14, 2013 | — | $-0.30 | — | — |
Q2 2013 | May 17, 2013 | — | $-0.33 | — | — |
Q4 2012 | Dec 31, 2012 | — | $-0.63 | — | — |
Q4 2012 | Nov 15, 2012 | — | $-0.46 | — | — |
Q2 2012 | Jun 30, 2012 | — | $-0.39 | — | — |
Q1 2012 | Mar 31, 2012 | — | $-1.22 | — | — |
Q4 2011 | Dec 31, 2011 | — | $-0.78 | — | — |
Q3 2011 | Sep 30, 2011 | — | $-0.73 | — | — |
Q2 2011 | Jun 30, 2011 | — | $-1.44 | — | — |
Latest News
Loading news...
Frequently Asked Questions about POSC
What is POSC's current stock price?
Positron Corporation (POSC) is currently trading at $1.55 per share. The stock has moved -2.08% today.
What is the analyst price target for POSC?
No analyst price targets are currently available for this stock.
What sector is Positron Corporation in?
Positron Corporation operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the OTC exchange.
What is POSC's market cap?
Positron Corporation has a market capitalization of $0.02 billion, making it a small-cap company.
Does POSC pay dividends?
No, Positron Corporation does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorASAPF
Aurora Spine Corporation
$0.20
Mkt Cap: $0.0B
BTCY
Biotricity, Inc.
$0.39
Mkt Cap: $0.0B
EMITF
Elbit Imaging Ltd.
$0.05
Mkt Cap: $0.0B
FNCH
Finch Therapeutics Group, Inc.
$13.82
Mkt Cap: $0.0B
GBLP
Global Pharmatech, Inc.
$0.05
Mkt Cap: $0.0B
GTHP
Guided Therapeutics, Inc.
$0.35
Mkt Cap: $0.0B
OXBOF
Oxford BioDynamics Plc
$0.00
Mkt Cap: $0.0B
PETV
PetVivo Holdings, Inc.
$1.16
Mkt Cap: $0.0B
PYNKF
Perimeter Medical Imaging AI, Inc.
$0.24
Mkt Cap: $0.0B
VASO
Vaso Corporation
$0.17
Mkt Cap: $0.0B
Explore stocks similar to POSC for comparison